Skip to main content
Mukta Arora, MD, Oncology, Minneapolis, MN

MuktaAroraMD

Oncology Minneapolis, MN

Hematologic Oncology

Associate Professor, Medicine, University of Minnesota Medical School

Dr. Arora is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Arora's full profile

Already have an account?

  • Office

    516 Delaware Street SE
    UNIV of MN Physicians PWB Fifth floor Clinic 5B
    Minneapolis, MN 55455
    Phone+1 612-273-2800
    Fax+1 612-625-6919

Summary

  • Dr. Mukta Arora is a Hematologist in Minneapolis, MN and is affiliated with University of Minnesota Medical Center, Fairview. She received her medical degree from King George's Medical College and completed a residency in Internal Medicine and Fellowship in Hematology and Oncology from University of Minnesota and has been in practice 17 years. She specializes in and is experienced in stem cell transplantation.

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine, 2001 - 2002
  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 1997 - 2000
  • King George's/CSM Medical College
    King George's/CSM Medical CollegeClass of 1993

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2002 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source, Conditioning Regiment Toxicity, and Engraftment Kinetics  
    Erhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel J Weisdorf, Nelli Bejanyan, Claudio G Brunstein, Celalettin Ustun, Aleksandr Lazaryan, Ver..., Haematologica
  • A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...  
    Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica
  • Late Mortality After Allogeneic Blood or Marrow Transplantation in Childhood for Leukemia: A Report from the Blood or Marrow Transplant Survivor Study-2  
    Stephen J Forman, Daniel J Weisdorf, Donna Salzman, Mukta Arora, Saro H Armenian, Nature

Abstracts/Posters

  • Stroke Risk in Blood or Marrow Transplant (BMT) Survivors _ a Report from the BMT Survivor Study (BMTSS)
    Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...
    Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantatio...
    Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) - Results of the BMT Survivor Study (BMTSS) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • BMT Survivor Study Finds Significant Breast Cancer Risk in Young Women Who Received Total Body Irradiation
    BMT Survivor Study Finds Significant Breast Cancer Risk in Young Women Who Received Total Body IrradiationJuly 31st, 2020